Aldevron, a leading global manufacturer of DNA, RNA, and proteins used in cell and gene therapies and vaccine development, ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

An experimental mRNA vaccine against avian influenza virus H5N1 is highly effective in preventing severe illness and death in ...

This partnership will allow Aldevron to expand its capabilities in mRNA LNP encapsulation by incorporating Acuitas’ proprietary LNP encapsulation platform, increasing Aldevron’s services and ...

Acuitas previously secured a separate license for the lipid nanoparticle technology used in Pfizer/BioNTech's COVID-19 vaccine. Acuitas said CureVac omitted its scientists from patent ...

In a report released today, Roy Buchanan from JMP Securities reiterated a Buy rating on CureVac (CVAC – Research Report), with a price ...

Story updated at 9:57 p.m. The homes of University of Michigan regents have become the latest front for protesters demanding ...

Ontrak, Inc. (NASDAQ: OTRK) ("Ontrak" or the "Company"), a leading AI-powered and technology-enabled behavioral healthcare ...

In November 2023, Acuitas Therapeutics filed a lawsuit in Virginia federal court against CureVac, accusing it of failing to credit Acuitas on patents related to COVID-19 vaccines. Acuitas told the ...